Clinical Trials Directory

Trials / Completed

CompletedNCT01939236

Traditional Chinese Medicine for Treatment of Chronic Heart Failure

Traditional Chinese Medicine for Treatment of Chronic Heart Failure: A Multicenter Randomized Double-blind Placebo-controlled Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
220 (actual)
Sponsor
Beijing University of Chinese Medicine · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether traditional Chinese medicine as complementary treatment is safe and effective in the treatment of chronic heart failure.

Detailed description

Heart failure (HF) can be defined as an abnormality of cardiac structure or function leading to failure of heart to deliver oxygen at a rate commensurate with the requirements of the metabolizing tissues, despite normal filling pressures (or only at the expense of increased filling pressures). And according to the nature of the clinical presentation, HF is divided into acute or chronic HF. In 2003, a random sample survey of 15,518 urban or rural residents between 35 and 74 years old was made in China: the prevalence rate of heart failure was 0.9%, and according to the result, there was about 4,000,000 HF subjects in China. In China, the integrative treatment of western and traditional Chinese medicine (TCM) for HF is common and has been developed as a treatment model. TCM has been used in China and other south and east Asia countries for thousands of years. Syndrome differentiation and treatment variation are the basic principles in understanding and treatment of diseases. Investigators would like to test the hypothesis that it is efficacy and safety for patients to take TCM granules according to syndrome differentiation. The specific aims for the study were to evaluate the efficacy and safety of TCM in treating chronic heart failure (CHF).

Conditions

Interventions

TypeNameDescription
DRUGtraditional Chinese medicine1 bag of drug 2 times per day for 28 days according to syndrome differentiation. For example, the syndrome of one patient is qi deficiency and blood stasis, he will take drugs of qi deficiency and blood stasis each bag 2 times per day for 28days.
DRUGPlacebo (gummeline)Placebo of each syndrome differentiation has the same weight and smell as traditional Chinese medicine of corresponding syndrome differentiation. 1 bag of drug 2 times per day for 28 days according to syndrome differentiation. For example, the syndrome of one patient is qi deficiency and blood stasis, he will take drugs of qi deficiency and blood stasis each bag 2 times per day for 28 days.

Timeline

Start date
2010-05-01
Primary completion
2012-08-01
Completion
2012-09-01
First posted
2013-09-11
Last updated
2013-10-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01939236. Inclusion in this directory is not an endorsement.